Founded in 1989, Zhejiang Fengan Biopharmaceutical Co., Ltd . (hereinafter referred to as Fengan Biopharmaceutical) is a national high-tech enterprise focusing on the R&D, production and sales of biological products. Headquartered in Taizhou city of Zhejiang province, our company has 5 holding subsidiaries in Beijing, Hangzhou and other places. Up to now, our company has successively won the honorary titles of "Zhejiang Province Contract-abiding and Credit-worthy AAA Enterprise", "Provincial Green Enterprise", "Provincial Specialized-Precise-Special New Enterprise" and so on. Mr. Wu Haihai, chairman of our company, has won the honorary title of "Outstanding Entrepreneur" for many times.

Now, Fengan has established a provincial enterprise technology research and development center, a provincial research institute, a provincial high-tech enterprise research and development center, an academician and expert workstation and other pharmaceutical technology research and development systems, and has a group of high-quality professional and technical personnel. Moreover, our company has also established long-term industry-university-research cooperation with more than 20 scientific research institutes such as Peking University, Tsinghua University, China Pharmaceutical University, Southern University of Science and Technology, and Academy of Military Sciences of the Chinese People's Liberation Army, thus we have formed and obtained the complementary resources between enterprises and research institutes.

Fengan is the first drug manufacturer and quality standard drafting unit approved for marketing in China for the oral lyophilized powder of spleen aminopeptide (Fuketuo). Fuketuo is an original product of the Chinese Academy of Military Sciences, and is recognized as a high-tech product by the Zhejiang Provincial Department of Science and Technology, and was listed as a "Boutique Made in Zhejiang" in 2020. It is included in the "Interpretation of Therapeutic Drugs in the National Clinical Pathway (Pediatric Internal Medicine)", "Pediatric Respiratory Therapy", "Practical Textbooks for the Diagnosis and Treatment of Common Diseases at the Primary Level", "Pathogenesis and Evidence-based Treatment of Urticaria" and other professional textbooks. In 2013, Fuketuo was approved as the national patent extraction technology to ensure that the average molecular weight of peptide substances is controlled at about 3500Da, which has high therapeutic value for various diseases caused by immune dysfunction. Our company has a production base of 180,000 square meters, with modern production plants in different purification levels, and adopts the most advanced automated, intelligent and isolated production equipment in China. Fuketuo is the first of its kind to manufacture an oral formulation using the injectable standard. Fengan has a complete cold chain transportation system, and its marketing business covers all parts of China.

Upholding the spirit of craftsmanship, we have been focusing on the field of immune regulation for more than 30 years, and are committed to making products of "top, first, and unique " in China. Adhering to the original mission of "get survival by good quality, get development by making innovation", we work for human health, and strive to make outstanding contributions to the pursuit of "building a solid immunization foundation for the whole people".